Ansøgeren anså forekomsten og omfanget af absorption for at være omtrent den samme for Rapinyl og Actiq og anså ligheden i de farmakokinetiske profiler i løbet af de første 30 minutters hurtige absorptionsfase for at være underbygget.
The Applicant considered the rate and extent of absorption to be similar for Rapinyl and Actiq and that the similarity in the PK profiles during the first 30-minute rapid absorption phase is established.